This is an external website. DAIC is not responsible for any content on the third party website.
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I blood test has received CE Mark for distribution ...
Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix ...
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is once ...
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...
February 3, 2016 — Abbott and Alere Inc. announced a definitive agreement for Abbott to acquire Alere. Under the terms ...
October 13, 2015 — The Lancet published results online that show Abbott’s ARCHITECT STAT High Sensitive Troponin-I ...
February 2, 2015 — The British Medical Journal published results online that show Abbott’s Architect Stat High Sensitive ...